TINIBA 500MG TABLET is used in the management of post-operative infections caused by anaerobic bacteria, especially those associated with colonic, gastrointestinal and gynecological surgery. It is also used to manage intraperitoneal infections, gynecological infections, bacterial septicemia, post-operative wound infections, skin and soft tissue infections, upper and lower respiratory tract infections, non-specific vaginitis, acute ulcerative gingivitis, urogenital trichomoniasis in both male and female patients, giardiasis, intestinal amebiasis, amebic involvement of the liver. It contains Tinidazole which belongs to the group of medicines known as Anti-protozoals. It works against anaerobic bacteria and protozoa is believed to involve the penetration of the medicine into the cell of the microorganism and subsequent damage of DNA strands or inhibition of their synthesis.
TINIBA 500MG TABLET is not recommended for patients with organic neurological disorders and blood dyscrasias. TINIBA 500MG TABLET should be used with caution in patients with liver disease. It is not recommended for patients with first trimester in pregnancy. TINIBA 500MG TABLET is not recommended for use in breastfeeding mother.
There is no proper data available for the use of TINIBA 500MG TABLET in children and adolescents below 12 years of age. The most common side effect of taking TINIBA 500MG TABLET are decreased appetite, headache, vertigo, vomiting, diarrhoea, nausea or abdominal pain. Consult your doctor if the side effects worsens or persists for a longer duration.
No content available
